AssetMark’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.76M Buy
250,606
+27,640
+12% +$651K 0.01% 708
2026
Q2
$5.3M Buy
222,966
+10,891
+5% +$260K 0.01% 713
2026
Q1
$5.06M Buy
212,075
+2,879
+1% +$69.4K 0.01% 659
2025
Q4
$5.06M Buy
209,196
+14,125
+7% +$342K 0.01% 653
2025
Q3
$4.71M Buy
+195,071
New +$4.69M 0.01% 634

Other funds holding IBD

AssetMark's IBD Position: Q3 2026 in Review

AssetMark increased its Inspire Corporate Bond ETF (IBD) stake by 12% in Q3 2026, buying an estimated $651K and bringing the position to 250,606 shares worth $5.76M. The position accounts for 0.01% of the portfolio, ranked #708.

AssetMark first reported a position in IBD in Q3 2025 and has held it in 5 quarters since. 97 funds tracked by Wall St. Rank hold IBD as of Q3 2026.

  • AssetMark held 250,606 shares of Inspire Corporate Bond ETF worth $5.76M as of Q3 2026.
  • AssetMark bought 27,640 Inspire Corporate Bond ETF shares in Q3 2026, an estimated $651K.
  • Inspire Corporate Bond ETF made up 0.01% of AssetMark's portfolio in Q3 2026, its #708 holding.
  • AssetMark first reported a position in Inspire Corporate Bond ETF in Q3 2025 and has held it in 5 quarters since.
  • 97 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.